Liver Fibrosis as Assessed by the FIB-4 Index in Patients with Type 2 Diabetes (T2DM)

Data about liver fibrosis in T2DM are scarce. The FIB-4 index is a non-invasive panel to evaluate underlying hepatic fibrosis. FIB-4 values Conclusion: Only 75% of the patients had FIB-4 suggesting absence of advanced liver fibrosis, ∼ 50% of subjects at risk of liver outcomes had ALT/AST within RR. FIB-4 is a simple, inexpensive method that may help identify patients at risk of liver outcomes. Strategies to slow the growth of liver complications and therapeutic options are necessary to mitigate disease burden. Disclosure C.M. Filozof: Employee; Self; Covance Inc.. S. Jones: None. B.J. Goldstein: Employee; Self; Covance Inc..